A large meta-analysis reviewed the benefits and risks associated with various treatments used for pediatric pain. One class of drugs stands out in particular.
Originally launched in 2006, the list aims to help pharmacies and other healthcare organizations by highlighting dangerous abbreviations, symbols and dose designations to avoid.